<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Med Imaging</journal-id><journal-id journal-id-type="iso-abbrev">BMC Med Imaging</journal-id><journal-title-group><journal-title>BMC Medical Imaging</journal-title></journal-title-group><issn pub-type="epub">1471-2342</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11786449</article-id><article-id pub-id-type="publisher-id">1576</article-id><article-id pub-id-type="doi">10.1186/s12880-025-01576-6</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Hyperspectral imaging in living and deceased donor kidney transplantation</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Wrigge</surname><given-names>Rasmus</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Sucher</surname><given-names>Robert</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Haak</surname><given-names>Fabian</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Meyer</surname><given-names>Hans-Jonas</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Unruh</surname><given-names>Julia</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Hau</surname><given-names>Hans-Michael</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Mehdorn</surname><given-names>Matthias</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Tautenhahn</surname><given-names>Hans-Michael</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Seehofer</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Scheuermann</surname><given-names>Uwe</given-names></name><address><email>uwe.scheuermann@medizin.uni-leipzig.de</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/028hv5492</institution-id><institution-id institution-id-type="GRID">grid.411339.d</institution-id><institution-id institution-id-type="ISNI">0000 0000 8517 9062</institution-id><institution>Department of Visceral, Transplantation, Vascular and Thoracic Surgery, </institution><institution>University Hospital of Leipzig, </institution></institution-wrap>Liebigstrasse 20, Leipzig, 04103 Germany </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02n0bts35</institution-id><institution-id institution-id-type="GRID">grid.11598.34</institution-id><institution-id institution-id-type="ISNI">0000 0000 8988 2476</institution-id><institution>Department of General-, Visceral- and Transplant Surgery, </institution><institution>Medical University of Graz, </institution></institution-wrap>Graz, Austria </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/028hv5492</institution-id><institution-id institution-id-type="GRID">grid.411339.d</institution-id><institution-id institution-id-type="ISNI">0000 0000 8517 9062</institution-id><institution>Department of Diagnostic and Interventional Radiology, </institution><institution>University Hospital of Leipzig, </institution></institution-wrap>Leipzig, Germany </aff></contrib-group><pub-date pub-type="epub"><day>31</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>31</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>25</volume><elocation-id>34</elocation-id><history><date date-type="received"><day>23</day><month>9</month><year>2024</year></date><date date-type="accepted"><day>28</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><sec><title>Objective and background</title><p id="Par1">Hyperspectral imaging (HSI) is an innovative, noninvasive technique that assesses tissue and organ perfusion and oxygenation. This study aimed to evaluate HSI as a predictive tool for early postoperative graft function and long-term outcomes in living donor (LD) and deceased donor (DD) kidney transplantation (KT).</p></sec><sec><title>Patients and methods</title><p id="Par2">HSI of kidney allograft parenchyma from 19 LD and 51 DD kidneys was obtained intraoperatively 15 minutes after reperfusion. Using the dedicated HSI TIVITA Tissue System, indices of tissue oxygenation (StO<sub>2</sub>), perfusion (near-infrared [NIR]), organ hemoglobin (OHI), and tissue water (TWI) were calculated and then analyzed retrospectively.</p></sec><sec><title>Results</title><p id="Par3">LD kidneys had superior intraoperative HSI values of StO<sub>2</sub> (0.78 &#x000b1; 0.13 versus 0.63 &#x000b1; 0.24; <italic>P</italic>&#x02009;=&#x02009;0.001) and NIR (0.67 &#x000b1; 0.10 versus 0.56 &#x000b1; 0.27; <italic>P</italic>&#x02009;=&#x02009;0.016) compared to DD kidneys. Delayed graft function (DGF) was observed in 18 cases (26%), in which intraoperative HSI showed significantly lower values of StO<sub>2</sub> (0.78 &#x000b1; 0.07 versus 0.35 &#x000b1; 0.21; <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001) and NIR (0.67 &#x000b1; 0.11 versus 0.34 &#x000b1; 0.32; <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001). Receiver operating characteristic curve analysis demonstrated an excellent predictive value of HSI for the development of DGF, with an area under the curve of 0.967 for StO<sub>2</sub> and 0.801 for NIR. Kidney grafts with low StO<sub>2</sub> values (cut-off point 0.6) showed reduced renal function with a low glomerular filtration rate and elevated urea levels in the first two weeks after KT. Three years after KT, graft survival was also inferior in the group with initially low StO<sub>2</sub> values.</p></sec><sec><title>Conclusion</title><p id="Par4">HSI is a useful tool for predicting DGF in living and deceased KT and may assist in estimating short-term allograft function. However, further studies with expanded cohorts are needed to evaluate the association between HSI and long-term graft outcomes.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s12880-025-01576-6.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Hyperspectral imaging</kwd><kwd>Living donor</kwd><kwd>Deceased donor</kwd><kwd>Kidney transplantation</kwd><kwd>Delayed graft function</kwd><kwd>Outcome</kwd></kwd-group><funding-group><award-group><funding-source><institution>Universit&#x000e4;tsklinikum Leipzig (8929)</institution></funding-source></award-group><open-access><p>Open Access funding enabled and organized by Projekt DEAL.</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; BioMed Central Ltd., part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par35">Despite improvements in organ preservation, surgical techniques and immunosuppressive therapy, many grafts following kidney transplantation (KT) still show impaired early posttransplant organ function and poor long-term graft survival. Although many donor and recipient risk factors have been identified to improve organ allocation and estimate postoperative graft function [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>], there are still unpredictable individual outcomes. Thus, some grafts exhibit delayed graft function (DGF), often associated with poor allograft survival [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par36">Hyperspectral imaging (HSI), a new, non-invasive measurement technique that allows quantitative analysis of several tissue parameters, such as tissue perfusion, has shown encouraging findings in multiple surgical applications [<xref ref-type="bibr" rid="CR5">5</xref>&#x02013;<xref ref-type="bibr" rid="CR8">8</xref>]. By providing color images of the surgical field representing oxygenation saturation (StO<sub>2</sub>), tissue perfusion (near-infrared [NIR] perfusion index), organ hemoglobin index (OHI), and tissue water index (TWI), the quality of allograft reperfusion can be visualized using HSI [<xref ref-type="bibr" rid="CR9">9</xref>]. Two previous studies revealed great potential for predicting DGF in deceased donor (DD) KT [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. However, HSI has never been tested in living donor (LD) KT, and no studies have reviewed its predictive value for long-term allograft outcomes.</p><p id="Par37">Therefore, our study aimed to demonstrate and compare the short- and long-term outcomes of patients receiving DD and LD KT based on intraoperative HSI.</p></sec><sec id="Sec2"><title>Patients and methods</title><sec id="Sec3"><title>Data collection and study population</title><p id="Par38">Medical data from all adult patients (&#x02265;&#x02009;18 years of age) who underwent initial LD or DD KT at the University Hospital of Leipzig between January 2019 and December 2020 were retrospectively analyzed. Exclusion criteria were a multiple organ transplant or a previous transplant. Follow-up data were collected until March 2024. The data source was a prospectively collected structured query language database. The study was approved by the institutional review board of the Medical University of Leipzig (AZ 111-16-14032016).</p><p id="Par39">Patient characteristics evaluated in the study population included donor and recipient age, gender, body mass index (BMI, weight in kg/ height in m<sup>2</sup>), donor cause of death, recipient cause of end-stage renal disease (ESRD), and dialysis duration.</p><p id="Par40">The estimated glomerular filtration rate (GFR) was calculated with the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation (mL/ min/ 1.73 m<sup>2</sup> of standard body surface area) using serum creatinine levels [<xref ref-type="bibr" rid="CR12">12</xref>].</p><p id="Par41">Furthermore, DDs were categorized into standard criteria donors (SCD) and expanded criteria donors (ECD) based on Rao et al.&#x02019;s definition [<xref ref-type="bibr" rid="CR13">13</xref>]. All donors under the age of 50 years were defined as SCDs, and all donors older than 60 years were described as ECDs, independent of the cause of death. Donors between 50 and 59 years of age with at least two of the following criteria: history of hypertension, cerebrovascular death, and serum creatinine levels over 1.5 mg/dL were categorized as ECDs, all others were classified as SCDs [<xref ref-type="bibr" rid="CR13">13</xref>].</p><p id="Par42">The investigated perioperative and posttransplant data included surgery time, cold ischemia time (CIT), and warm ischemia time (WIT) of the kidneys. Notably, CIT is defined as the duration from the beginning of organ cold perfusion until the organ is removed from ice, while WIT is the time from cross-clamping until cold perfusion plus the anastomosis time (organ out of ice until reperfusion). During anastomosis time, cold lap pads irrigated with cold saline were utilized to prevent the warming of the organs.</p><p id="Par43">Organ procurement, transplantation, induction therapy and initial immunosuppression were performed as described previously [<xref ref-type="bibr" rid="CR2">2</xref>]. Adequate intravenous fluid supply ensures sufficient mean arterial pressure (80 mmHg) during organ reperfusion.</p></sec><sec id="Sec4"><title>Outcome measures</title><p id="Par44">The outcome data included DGF, initial non-function (INF), biopsy-proven or clinically suspected and accordingly treated acute rejection in the first year after KT, date and cause of graft failure, and patient death. INF was defined as dialysis dependence or creatinine clearance&#x02009;&#x02264;&#x02009;20 mL/ min at three months post-transplant. DGF was defined as the need for dialysis in the first week following transplantation [<xref ref-type="bibr" rid="CR14">14</xref>]. Graft failure was described as a return to dialysis or pre-emptive transplant. Post-operative deaths included all deaths occurring within 30 days after surgery.</p></sec><sec id="Sec5"><title>Intraoperative kidney reperfusion assessment with HSI</title><p id="Par45">Non-invasive hyperspectral images acquisition was performed intraoperatively using the TIVITA&#x000ae; Tissue HSI system (Diaspective Vision, Am Salzhaff, Germany), as described earlier by our study group [<xref ref-type="bibr" rid="CR10">10</xref>].</p><p id="Par46">The HSI method is based on the physical principles of optical remission spectroscopy. After being irradiated with white light in the visible and NIR range (400&#x02013;100 nm), inhomogeneities in the tissue structure result in contrasting light scattering, while various tissue compounds can alter light absorption. Therefore, various tissue properties result in the remission of light with a range of wavelengths detectable by the HSI camera system.</p><p id="Par47">As hemoglobin and water also impact incident light, the technique allows the determination of the perfusion state of the examined kidneys, calculating indices for the organ&#x02019;s oxygenation, perfusion, hemoglobin, and water content [<xref ref-type="bibr" rid="CR15">15</xref>].</p><p id="Par48">After darkening the surrounding light sources in the operating room to ensure undisturbed image acquisition and data generation, pictures with a high spectral resolution (5 nm) in the visible and NIR range (500&#x02013;1,000 nm) where obtained 15 minutes after reperfusion using the push broom HSI system.</p><p id="Par49">The camera was located 30 cm from the transplanted organ with a moving arm to acquire the image using a 25-mm focal lens. Exact positioning was ensured by the device&#x02019;s integrated electro-optical distance measurement system, resulting in a field of view (FOV) of 6.4 &#x000d7; 4.8 cm&#x000b2; and creating pictures with 640 &#x000d7; 480 (x- and y-axes) effective pixels (spatial resolution of 0.1 mm/pixel).</p><p id="Par50">The acquired information is transformed into a hyperspectral data cube using the HSI camera system software, as described earlier (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>) [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR16">16</xref>].</p><p id="Par51">
<fig id="Fig1"><label>Fig. 1</label><caption><p>TIVITA&#x000ae; system for medical hyperspectral imaging (HSI). <bold>A</bold>&#x000a0;TIVITA&#x000ae; camera system is installed on a mobile cart. The camera is attached to a holding arm and has an integrated light source. The spectrograph inside the camera is moved over the image plane for HSI measurement. The acquired HSI-Data can be displayed as false-color images on the monitor intraoperatively. <bold>B</bold>&#x000a0;Reflected light from the measured object is captured by the objective lens (1) to focus it on the entrance slit (2) of the spectrograph. Special lenses (3 and 5) and a transmission grating (4) split the light, depending on the wavelength, into several beams. For digital processing, the beams are captured by a monochromatic image sensor (6). TIVITA&#x000ae; Tissue HSI system (Diaspective Vision, Am Salzhaff, Germany)</p></caption><graphic xlink:href="12880_2025_1576_Fig1_HTML" id="MO1"/></fig></p><p id="Par52">The software provides an RGB image and four color-coded images of the inspected kidney less than eight seconds after the acquisition, representing StO<sub>2</sub>, tissue perfusion (NIR), OHI, and TWI. The percentage of StO<sub>2</sub> (0&#x02013;100%) is presented in decimal fractions (0&#x02013;1). While microcirculatory tissue oxygenation in superficial layers (up to 1 mm penetration depth) is displayed by StO<sub>2</sub>, the NIR perfusion index depicts renal tissue layers in 4&#x02013;6mm penetration depth. The distribution of hemoglobin and water in the FOV is represented by the indices OHI and TWI [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR15">15</xref>&#x02013;<xref ref-type="bibr" rid="CR17">17</xref>].</p><p id="Par53">After prospective collection and intraoperative review of the images generated by the TIVITA&#x000ae; software, they were analyzed by retrospectively inserting round markers to identify our region of interest (ROI). Areas of the kidney surface without adherent perirenal fat or light reflection artefacts were selected as ROI. For each parameter, the index average inside the ROI was calculated (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>).</p><p id="Par54">
<fig id="Fig2"><label>Fig. 2</label><caption><p>Representative intraoperative HSI images of a LD-KT allograft 15 minutes after reperfusion. RGB image and false color hyperspectral images for oxygenation (StO<sub>2</sub>), tissue perfusion (NIR), hemoglobin (OHI) and tissue water (TWI). The ROI (white circle) is marked within the parenchyma of kidney allograft. HSI, Hyperspectral imaging; KT, kidney transplant; LD, living donor; NIR, near-infrared perfusion index; OHI, organ hemoglobin index; RGB, red green blue; ROI, region of interest; StO2, oxygen saturation; TWI, tissue water index</p></caption><graphic xlink:href="12880_2025_1576_Fig2_HTML" id="MO2"/></fig></p></sec><sec id="Sec6"><title>Statistical analysis</title><p id="Par55">Continuous variables were compared using Welch&#x02019;s t-test, while categorical variables were compared using &#x003c7;&#x000b2; test or Fisher exact test. Multivariate Cox proportional hazard was used to evaluate independent predictors of kidney graft failure. Receiver operating characteristic (ROC) curves were used to assess the prognostic values of the HSI parameters in predicting DGF. In addition, the Youden index was employed to calculate the optimal cut-point value [<xref ref-type="bibr" rid="CR18">18</xref>]. Diagnostic accuracy was measured by the area under the ROC curve (AUC). Higher AUC values indicate greater accuracy, whereas an AUC of 1.0 represents perfect sensitivity and specificity; an AUC of 0.5 indicates an essentially worthless test. The parametric bootstrap was used to construct confidence intervals. Survival rates were calculated using Kaplan&#x02013;Meier analysis, and the log-rank test was applied to test statistical significance. Graft survival was calculated as the time from initial transplant to graft failure or patient death, additionally analyzing graft survival censoring for death with a functioning graft (death-censored graft survival). Patient survival was defined as the time from transplant to patient death, with patients still alive at the time of analysis censored. If a recipient was alive or lost to follow-up at the time of the last contact, the survival time was censored at the time of the last contact. SPSS 29.0 (SPSS Inc., Chicago, Illinois, USA) and Graph Pad Prism 10 (San Diego, CA, USA) were used for the statistical analysis. A <italic>P</italic>-value&#x02009;&#x0003c;&#x02009;0.05 was defined as statistically significant. Baseline data are presented as mean values and standard deviations (SD).</p></sec></sec><sec id="Sec7"><title>Results</title><sec id="Sec8"><title>Study population</title><p id="Par56">A total of 70 patients were included in the analysis (51 deceased and 19 living KT). The patient characteristics of the study population are shown in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>. Most donor and recipient parameters were similar between living and deceased KT. Compared to DD-KT recipients, recipients of LD kidneys were significantly younger (56.3 &#x000b1; 13.4 years versus 44.9 &#x000b1; 12.5 years; <italic>P</italic>&#x02009;=&#x02009;0.002) and had spent less time on dialysis before transplant (85.7 &#x000b1; 44.4 months versus 32.2 &#x000b1; 31.2 months; <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001). Four KTs (21.1%) were performed preemptively in the LD group. Twenty-six donors in the DD-KT (51%) cohort were ECDs. Four blood group-incompatible transplants were performed (21.1%) in the LD-KT cohort. Furthermore, CIT was significantly prolonged in KT after deceased donation (580 &#x000b1; 222 minutes versus 138 &#x000b1; 42 minutes, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001), whereas WITs were comparable between the groups (<italic>P</italic>&#x02009;=&#x02009;0.200). There were no postoperative deaths.
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Donor, recipient and transplant characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Variables</th><th align="left">DD (<italic>N</italic> = 51)</th><th align="left">LD (<italic>N</italic> = 19)</th><th align="left"><italic>P</italic>-value</th></tr></thead><tbody><tr><td align="left" colspan="4">Donor</td></tr><tr><td align="left">&#x02003;Age, years</td><td align="left">54.5 &#x000b1; 17.5</td><td align="left">57.5 &#x000b1; 8.5</td><td align="left">0.338</td></tr><tr><td align="left">&#x02003;Gender, male/ female, n (%)</td><td align="left">26 (51.0)/ 25 (49.0)</td><td align="left">7 (36.8)/ 12 (63.2)</td><td align="left">0.292</td></tr><tr><td align="left">&#x02003;BMI, kg/m<sup>2</sup></td><td align="left">26.0 &#x000b1; 3.7</td><td align="left">27.5 &#x000b1; 4.5</td><td align="left">0.209</td></tr><tr><td align="left" colspan="4">&#x02003;Comorbidity, n (%)</td></tr><tr><td align="left">&#x02003;&#x02003;Hypertension</td><td align="left">20 (39.2)</td><td align="left">5 (26.3)</td><td align="left">0.317</td></tr><tr><td align="left">&#x02003;&#x02003;Diabetes mellitus</td><td align="left">1 (2.0)</td><td align="left">2 (10.5)</td><td align="left">0.116</td></tr><tr><td align="left" colspan="4">Recipient</td></tr><tr><td align="left">&#x02003;Age, years</td><td align="left">56.3 &#x000b1; 13.4</td><td align="left">44.9 &#x000b1; 12.5</td><td align="left">0.002</td></tr><tr><td align="left">&#x02003;Gender, male/ female, n (%)</td><td align="left">36 (70.6)/ 15 (29.4)</td><td align="left">13 (68.4)/ 6 (31.6)</td><td align="left">0.860</td></tr><tr><td align="left">&#x02003;BMI, kg/m<sup>2</sup></td><td align="left">26.4 &#x000b1; 4.1</td><td align="left">26.2 &#x000b1; 4.6</td><td align="left">0.864</td></tr><tr><td align="left">&#x02003;ESRD GN, n (%)</td><td align="left">18 (35.3)</td><td align="left">8 (42.1)</td><td align="left">0.600</td></tr><tr><td align="left" colspan="4">&#x02003;Comorbidity, n (%)</td></tr><tr><td align="left">&#x02003;&#x02003;Hypertension</td><td align="left">41 (80.4)</td><td align="left">14 (73.7)</td><td align="left">0.531</td></tr><tr><td align="left">&#x02003;&#x02003;Diabetes mellitus</td><td align="left">7 (13.7)</td><td align="left">3 (15.8)</td><td align="left">0.826</td></tr><tr><td align="left">&#x02003;Time on dialysis, months</td><td align="left">85.7 &#x000b1; 44.4</td><td align="left">32.3 &#x000b1; 31.2</td><td align="left">&#x0003c;0.001</td></tr><tr><td align="left" colspan="4">Transplant</td></tr><tr><td align="left">&#x02003;CMV D+R-, n (%)</td><td align="left">20 (39.2)</td><td align="left">4 (21.1)</td><td align="left">0.155</td></tr><tr><td align="left">&#x02003;HLA mismatch &#x02265;4, n (%)</td><td align="left">24 (47.1)</td><td align="left">10 (52.6)</td><td align="left">0.678</td></tr><tr><td align="left">&#x02003;PRA positive, n (%)</td><td align="left">19 (37.3)</td><td align="left">1 (5.3)</td><td align="left">0.006</td></tr><tr><td align="left">&#x02003;CIT, minutes</td><td align="left">580 &#x000b1; 222.0</td><td align="left">138 &#x000b1; 41.9</td><td align="left">&#x0003c;0.001</td></tr><tr><td align="left">&#x02003;WIT total, minutes</td><td align="left">39 &#x000b1; 10.9</td><td align="left">36 &#x000b1; 5.5</td><td align="left">0.200</td></tr><tr><td align="left">&#x02003;Surgery time, minutes</td><td align="left">184 &#x000b1; 45.8</td><td align="left">173 &#x000b1; 39.7</td><td align="left">0.328</td></tr><tr><td align="left" colspan="4">Outcome</td></tr><tr><td align="left">&#x02003;DGF, n (%)</td><td align="left">15 (29.4)</td><td align="left">3 (15.8)</td><td align="left">0.360</td></tr><tr><td align="left">&#x02003;Hospital stay, days</td><td align="left">23 &#x000b1; 15.2</td><td align="left">27 &#x000b1; 29.9</td><td align="left">0.530</td></tr><tr><td align="left">&#x02003;Rejection first year, n (%)</td><td align="left">11 (21.6)</td><td align="left">5 (26.3)</td><td align="left">0.752</td></tr></tbody></table><table-wrap-foot><p><italic>BMI</italic>&#x000a0;body mass index, <italic>CIT</italic>&#x000a0;cold ischemia time, <italic>CMV D&#x02009;+&#x02009;R-</italic>&#x000a0;high risk cytomegalovirus status: donor+/ recipient-, <italic>DGF</italic>&#x000a0;delayed graft function, <italic>ESRD GN</italic>&#x000a0;end-stage renal disease glomerulonephritis, <italic>HLA</italic>&#x000a0;human leukocyte antigen, <italic>KT</italic> kidney transplantation, <italic>LD</italic>&#x000a0;living donor, <italic>nDGF</italic>&#x000a0;non-delayed graft function, <italic>PRA</italic>&#x000a0;panel reactive antibody, <italic>WIT</italic>&#x000a0;warm ischemia time</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec9"><title>Living and deceased kidney transplants</title><p id="Par57">Fifteen minutes after reperfusion, the LD kidney grafts showed significantly higher values of StO<sub>2</sub> (LD: 0.78 &#x000b1; 0.13 versus DD: 0.63 &#x000b1; 0.24; <italic>P</italic>&#x02009;=&#x02009;0.001) and NIR (LD: 0.67 &#x000b1; 0.10 versus DD: 0.56 &#x000b1; 0.27; <italic>P</italic>&#x02009;=&#x02009;0.016) than the KT after deceased donation. Furthermore, OHI and TWI showed no significant difference between living and deceased KT (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>).</p><p id="Par58">
<fig id="Fig3"><label>Fig. 3</label><caption><p>HSI-Data of the total cohort comparing DD and LD kidney grafts 15 minutes after reperfusion. DD, deceased donor; HSI, Hyperspectral imaging; LD, living donor; NIR, near-infrared perfusion index; OHI, organ hemoglobin index; StO2, oxygen saturation; TWI, tissue water index. *<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05 **<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01; NS, not significant</p></caption><graphic xlink:href="12880_2025_1576_Fig3_HTML" id="MO3"/></fig></p></sec><sec id="Sec10"><title>Delayed graft function</title><p id="Par59">Eighteen patients (26%) showed DGF. Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref> compares KT with and without DGF (nDGF). Donor characteristics were comparable between the groups. Transplant kidneys developing DGF were associated with a significantly prolonged CIT (<italic>P</italic>&#x02009;=&#x02009;0.043), surgery time (<italic>P</italic>&#x02009;=&#x02009;0.002), high recipient BMI (<italic>P</italic>&#x02009;=&#x02009;0.015), and extended time on dialysis before transplantation (<italic>P</italic>&#x02009;=&#x02009;0.039). There were no significant differences in the incidence rate of DGF regarding the type of organ donation (LD: 3 (16%) versus DD: 15 (29%); <italic>P</italic>&#x02009;=&#x02009;0.360) or differences in DGF development when comparing ECD with SCD and LD (<italic>P</italic>&#x02009;=&#x02009;0.468).
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Donor, recipient and transplant characteristic according to development of delayed graft function</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Variables</th><th align="left">nDGF (<italic>N</italic> = 52)</th><th align="left">DGF (<italic>N</italic> = 18)</th><th align="left"><italic>P</italic>-value</th></tr></thead><tbody><tr><td align="left" colspan="4">Donor</td></tr><tr><td align="left">&#x02003;Age, years</td><td align="left">55.8 &#x000b1; 16.4</td><td align="left">53.9 &#x000b1; 13.4</td><td align="left">0.635</td></tr><tr><td align="left">&#x02003;Gender, male/ female, n (%)</td><td align="left">22 (42.3)/ 30 (57.7)</td><td align="left">11 (61.1)/ 7 (38.9)</td><td align="left">0.168</td></tr><tr><td align="left">&#x02003;BMI, kg/m<sup>2</sup></td><td align="left">26.0 &#x000b1; 3.9</td><td align="left">27.5 &#x000b1; 4.1</td><td align="left">0.170</td></tr><tr><td align="left" colspan="4">&#x02003;Comorbidity, n (%)</td></tr><tr><td align="left">&#x02003;&#x02003;Hypertension</td><td align="left">17 (32.7)</td><td align="left">8 (44.4)</td><td align="left">0.370</td></tr><tr><td align="left">&#x02003;&#x02003;Diabetes mellitus</td><td align="left">2 (3.8)</td><td align="left">1 (5.6)</td><td align="left">0.758</td></tr><tr><td align="left" colspan="4">Recipient</td></tr><tr><td align="left">&#x02003;Age, years</td><td align="left">52.8 &#x000b1; 14.4</td><td align="left">54.3 &#x000b1; 13.3</td><td align="left">0.695</td></tr><tr><td align="left">&#x02003;Gender, male/ female, n (%)</td><td align="left">35 (67.3)/ 14 (26.9)</td><td align="left">14 (77.8)/ 4 (22.2)</td><td align="left">0.403</td></tr><tr><td align="left">&#x02003;BMI, kg/m<sup>2</sup></td><td align="left">25.6 &#x000b1; 3.9</td><td align="left">28.6 &#x000b1; 4.3</td><td align="left">0.015</td></tr><tr><td align="left">&#x02003;ESRD GN, n (%)</td><td align="left">20 (38.5)</td><td align="left">6 (33.3)</td><td align="left">0.698</td></tr><tr><td align="left" colspan="4">&#x02003;Comorbidity, n (%)</td></tr><tr><td align="left">&#x02003;&#x02003;Hypertension</td><td align="left">41 (78.8)</td><td align="left">14 (77.8)</td><td align="left">0.924</td></tr><tr><td align="left">&#x02003;&#x02003;Diabetes mellitus</td><td align="left">5 (9.6)</td><td align="left">5 (27.8)</td><td align="left">0.058</td></tr><tr><td align="left">&#x02003;Time on dialysis, months</td><td align="left">66.0 &#x000b1; 45.7</td><td align="left">93.7 &#x000b1; 46.5</td><td align="left">0.039</td></tr><tr><td align="left" colspan="4">Transplant</td></tr><tr><td align="left">&#x02003;CMV D+R-, n (%)</td><td align="left">17 (32.7)</td><td align="left">7 (38.9)</td><td align="left">0.633</td></tr><tr><td align="left">&#x02003;HLA mismatch &#x02265;4, n (%)</td><td align="left">24 (46.2)</td><td align="left">10 (55.6)</td><td align="left">0.492</td></tr><tr><td align="left">&#x02003;PRA positive, n (%)</td><td align="left">13 (25.0)</td><td align="left">7 (38.9)</td><td align="left">0.327</td></tr><tr><td align="left">&#x02003;CIT, minutes</td><td align="left">419 &#x000b1; 245.8</td><td align="left">593 &#x000b1; 313.0</td><td align="left">0.043</td></tr><tr><td align="left">&#x02003;WIT total, minutes</td><td align="left">38 &#x000b1; 10.1</td><td align="left">38 &#x000b1; 9.4</td><td align="left">0.898</td></tr><tr><td align="left">&#x02003;Surgery time, minutes</td><td align="left">172 &#x000b1; 43.9</td><td align="left">206 &#x000b1; 35.6</td><td align="left">0.002</td></tr><tr><td align="left" colspan="4">Outcome</td></tr><tr><td align="left">&#x02003;Hospital stay, days</td><td align="left">19 &#x000b1; 12.1</td><td align="left">39 &#x000b1; 30.1</td><td align="left">0.014</td></tr><tr><td align="left">&#x02003;Rejection first year, n (%)</td><td align="left">10 (19.2)</td><td align="left">6 (33.3)</td><td align="left">0.219</td></tr></tbody></table><table-wrap-foot><p><italic>BMI</italic>&#x000a0;body mass index, <italic>CIT</italic>&#x000a0;cold ischemia time, <italic>CMV D&#x02009;+&#x02009;R-</italic>&#x000a0;high risk cytomegalovirus status: donor+ /recipient-, <italic>DGF</italic>&#x000a0;delayed graft function, <italic>ESRD GN</italic>&#x000a0;end-stage renal disease glomerulonephritis, <italic>HLA</italic>&#x000a0;human leukocyte antigen, <italic>KT</italic>&#x000a0;kidney transplantation, <italic>LD</italic>&#x000a0;living donor, <italic>nDGF</italic>&#x000a0;non-delayed graft function, <italic>PRA</italic>&#x000a0;panel reactive antibody, <italic>WIT</italic>&#x000a0;warm ischemia time.</p></table-wrap-foot></table-wrap></p><p id="Par60">Regarding the three kidney grafts with DGF after LD, one graft developed necrosis on the upper kidney pole after arterial reconstruction. Another LD kidney graft developed a subcapsular hemorrhage immediately after reperfusion. In addition, the third patient who developed DGF after LD exhibited a BMI of 37 kg/m<sup>2</sup> and a short renal artery and vein, thus complicating the implantation procedure and potentially being&#x000a0;responsible for the impaired reperfusion.</p><p id="Par61">After the transplant, patients developing DGF spent significantly increased time in the hospital before discharge (18.9 &#x000b1; 12.1 days versus 38.6 &#x000b1; 30.1 days; <italic>P</italic>&#x02009;=&#x02009;0.014). Seven DD-KT recipients and one LD-KT recipient showed INF (<italic>P</italic>&#x02009;=&#x02009;0.243).</p><p id="Par62">In the overall study population, intraoperative HSI showed significantly reduced values of StO<sub>2</sub> (0.78 &#x000b1; 0.07 versus 0.35 &#x000b1; 0.21; <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001) and NIR (0.67 &#x000b1; 0.11 versus 0.34 &#x000b1; 0.32; <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001) in grafts developing DGF. No significant differences were observed between the groups regarding the other HSI parameters (OHI and TWI). In the subgroup analysis, the same was observed in the DD-KT cohort (StO<sub>2</sub>: 0.76 &#x000b1; 0.07 versus 0.32 &#x000b1; 0.22; <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001; NIR: 0.67 &#x000b1; 0.12 versus 0.29 &#x000b1; 0.32; <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001) (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>A), whereas LD kidneys developing DGF only showed reduced values for StO<sub>2</sub> (0.83 &#x000b1; 0.05 versus 0.52 &#x000b1; 0.06; <italic>P</italic>&#x02009;=&#x02009;0.006) (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>B).</p><p id="Par63">
<fig id="Fig4"><label>Fig. 4</label><caption><p>HSI-Data of the <bold>A</bold>&#x000a0;deceased donor and <bold>B</bold>&#x000a0;living donor kidney transplant cohort according to occurrence of DGF. DD, deceased donor; DGF, delayed graft function; HSI, Hyperspectral imaging; LD, living donor; nDGF, non-delayed graft function; NIR, near-infrared perfusion index; OHI, organ hemoglobin index; StO<sub>2</sub>, oxygen saturation; TWI, tissue water index. **<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01 ***<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001; NS, not significant</p></caption><graphic xlink:href="12880_2025_1576_Fig4_HTML" id="MO4"/></fig></p><p id="Par64">The ROC curves and analysis of test accuracy are presented in Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>. Notably, AUCs were 0.967 for StO<sub>2</sub> and 0.801 for NIR, with sensitivity and specificity of 98.1% and 88.9% for StO<sub>2</sub> and 84.6% and 72.2% for NIR, respectively. Other parameters had limited predictive values. Bootstrapping analysis of HSI Data are presented in Suppl. Table&#x000a0;1.</p><p id="Par65">
<fig id="Fig5"><label>Fig. 5</label><caption><p><bold>A</bold>&#x000a0;Receiver operating characteristic (ROC) curves and <bold>B</bold>&#x000a0;analysis of HSI-data for development of delayed graft function. AUC, area under the curve; HSI, Hyperspectral imaging; NIR, near-infrared perfusion index; NPV, negative predictive value; PPV, positive predictive value; OHI, organ hemoglobin index; SE, standard error; Sens, sensitivity; Spec, specificity; StO<sub>2</sub>, oxygen saturation; TWI, tissue water index.; 95% CI, 95% confidence interval</p></caption><graphic xlink:href="12880_2025_1576_Fig5_HTML" id="MO5"/></fig></p></sec><sec id="Sec11"><title>Renal function</title><p id="Par66">LD und DD-KT cohorts showed similar values for urea and GFR on postoperative day 6 (Urea: LD: 14.9 &#x000b1; 11.4 versus DD: 16.6 &#x000b1; 8.7; <italic>P</italic>&#x02009;=&#x02009;0.571; GFR: LD: 38.6 &#x000b1; 24.9 versus DD: 27.8 &#x000b1; 18.4; <italic>P</italic>&#x02009;=&#x02009;0.096) and postoperative day 14 (Urea: LD: 11.2 &#x000b1; 6.1 versus DD: 12.9 &#x000b1; 8.9; <italic>P</italic>&#x02009;=&#x02009;0.371; GFR: LD: 44.0 &#x000b1; 22.9 versus DD: 36.5 &#x000b1; 19.0; <italic>P</italic>&#x02009;=&#x02009;0.212).</p><p id="Par67">For long-term outcome evaluation, we divided the cohort into two groups above and below the optimal cut-point value of StO<sub>2</sub> (StO<sub>2</sub> low and high) for the development of DGF (optimal cut-point value: StO<sub>2</sub>&#x02009;=&#x02009;60.7%). Figure&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref> shows the GFR and urea values among the groups within the first three years after KT. Recipients with low StO2-values in the LD and DD-KT cohorts had reduced values in the first two weeks after KT. No long-term differences were observed between the groups.</p><p id="Par68">
<fig id="Fig6"><label>Fig. 6</label><caption><p>Mean post-operative <bold>A</bold>&#x000a0;urea levels and <bold>B</bold>&#x000a0;glomerular filtration rates according to transplantation mode and intraoperative StO<sub>2</sub>. GFR, glomerular filtration rate; LD, living donor; DD, deceased donor; StO2, oxygen saturation</p></caption><graphic xlink:href="12880_2025_1576_Fig6_HTML" id="MO6"/></fig></p><p id="Par69">Due to limited sample size, an analysis of the correlation between NIR cut-off value and DD and LD renal function was not possible.</p></sec><sec id="Sec12"><title>Long-term survival</title><p id="Par70">The one- and three-year cumulative graft survival rates were 88.6% and 81.4%, respectively. According to initial StO<sub>2</sub>, one- and three-year graft survival rates were 76.5% and 64.7% for the low (<italic>N</italic>&#x02009;=&#x02009;17) StO<sub>2</sub> group and 92.5% and 86.8% for the high (<italic>N</italic>&#x02009;=&#x02009;53) StO<sub>2</sub> group (<italic>P</italic>&#x02009;=&#x02009;0.037), respectively.</p><p id="Par71">Cumulative death-censored graft survival rates were 95.7% and 91.4% after one and three years, respectively. Based on initial StO<sub>2</sub>, death-censored one- and three-year graft survival rates were 82.4% and 76.5% for the low (<italic>N</italic>&#x02009;=&#x02009;17) StO<sub>2</sub> group and 100% and 96.2% for the high (<italic>N</italic>&#x02009;=&#x02009;53) StO<sub>2</sub> group (<italic>P</italic>&#x02009;=&#x02009;0.009), respectively.</p><p id="Par72">Reasons for graft loss included rejection (<italic>N</italic>&#x02009;=&#x02009;2), fulminant graft infection (<italic>N</italic>&#x02009;=&#x02009;1), venous thrombosis of the transplant kidney (<italic>N</italic>&#x02009;=&#x02009;1) and septic shock (<italic>N</italic>&#x02009;=&#x02009;1). In one case, the cause of graft loss remained unclear. All cases of graft loss occurred in kidney grafts after deceased donation.</p><p id="Par73">The overall one- and three-year patient survival rates were 90.0% and 85.7%, respectively. The patient survival rates one and three years after KT were 82.4% and 70.6% in the group with low StO<sub>2</sub> and 92.5% and 90.6% in the group with high StO<sub>2</sub> (<italic>P</italic>&#x02009;=&#x02009;0.046), respectively.</p><p id="Par74">The causes of death included septic shock (<italic>N</italic>&#x02009;=&#x02009;5), stroke (<italic>N</italic>&#x02009;=&#x02009;2), cardiac arrest (<italic>N</italic>&#x02009;=&#x02009;1), and suicide (<italic>N</italic>&#x02009;=&#x02009;1). In one case, the cause of death was not ascertainable.</p><p id="Par75">Assessment of long-term survival according to NIR, OHI and TWI cut-point values did not result in significant differences (<italic>P</italic>&#x02009;&#x0003e;&#x02009;0.05 each).</p></sec></sec><sec id="Sec13"><title>Discussion</title><sec id="Sec14"><title>HSI in living kidney transplantation</title><p id="Par76">This is the first study to apply HSI in LD-KT and to evaluate the long-term outcomes of KT recipients based on HSI.</p><p id="Par77">In our study, LD kidney grafts showed significantly higher values of StO<sub>2</sub> and NIR after organ reperfusion than KT after deceased donation. The reasons for this observation are likely multifactorial. Generally, superior organ quality and shorter CITs contribute to the better outcome seen in living KT, as both factors could prevent a severe ischemia-reperfusion injury (IRI) and consecutively lead to improved microtissue perfusion and oxygenation. Moreover, as seen in our study, surgical complications, such as vascular occlusion and subcapsular hemorrhage after reperfusion or a longer WIT in cases of complicated implantation, can contribute to poor intraoperative HSI values and development of DGF.</p></sec><sec id="Sec15"><title>Prediction of postoperative renal function</title><p id="Par78">Pretransplant, the donor&#x02019;s and recipient&#x02019;s characteristics can help estimate future allograft function. However, they do not consider any impairment of the kidney during the transplantation process and thus are limited in predicting allograft outcomes [<xref ref-type="bibr" rid="CR19">19</xref>]. The HSI measurement after organ reperfusion can consider these risk factors and therefore provide crucial information about future organ function. Consequently, HSI could be used as an alternative or additional tool to established methods, such as protocol biopsies, during graft implantation. Especially as biopsies, unlike HSI measurement, are invasive and studies have shown that it does not benefit patients with a low risk of rejection [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>].</p><p id="Par79">Notably, DGF is a prevalent complication in kidney allografts, associated with poor graft performance and suboptimal long-term outcomes for recipients [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. Moreover, DGF leads to extended hospitalization, prolonged stays in intensive care units, and increased costs [<xref ref-type="bibr" rid="CR23">23</xref>]. Previous studies have reported a strong relationship between intraoperative HSI and the development of DGF in DD-KT [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. We confirmed these findings in LD-KT.</p><p id="Par80">A major factor contributing to DGF development is IRI, as restored blood flow damages the kidney parenchyma after prolonged ischemia [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. In organs with impaired graft function, it is challenging to distinguish between DGF resulting from IRI and organs requiring immediate therapy, such as grafts with acute rejection. Our study demonstrated reduced values for StO<sub>2</sub> and NIR in transplant kidneys developing DGF, possibly suggesting impaired microcirculatory tissue perfusion in the affected kidneys. </p><p id="Par81">After KT, allograft function is estimated using recipient serum creatinine levels or GFR. Nevertheless, this biomarker tends to increase only in the late stages of injury, limiting its utility in detecting early graft dysfunction [<xref ref-type="bibr" rid="CR25">25</xref>]. Promising new noninvasive biomarkers, such as neutrophil gelatinase-associated lipocalin, measured in urine samples, can indicate graft damage in kidneys with IRI. However, they are not yet used in daily clinical routines because their analytic process is too complex and protracted [<xref ref-type="bibr" rid="CR26">26</xref>]. Therefore, HSI, especially as a noninvasive method, is beneficial for additional organ assessment. The ability to detect early graft dysfunction would allow further diagnostic steps and close monitoring of the affected kidneys.</p></sec><sec id="Sec16"><title>Graft and patient survival</title><p id="Par82">For the first time, patients who underwent KT with intraoperative HSI measurement were surveilled for more than 12 months [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. Patients with reduced intraoperative StO<sub>2</sub> values showed inferior graft and patient survival compared to those with higher StO<sub>2</sub> values. However, our study cohort is too small to draw definitive conclusions about the predictive ability of HSI. More studies with expanded patient numbers are needed to evaluate this further.</p><p id="Par83">Other diagnostic methods, such as the resistive index measured by Doppler sonography, have also been tested in the KT setting; however, they have shown controversial results regarding their ability to predict short- and long-term outcomes [<xref ref-type="bibr" rid="CR27">27</xref>&#x02013;<xref ref-type="bibr" rid="CR30">30</xref>]. Indocyanine green (ICG) angiography may also represent a diagnostic tool for displaying microperfusion and predicting future graft outcomes [<xref ref-type="bibr" rid="CR31">31</xref>]. However, recent studies have found no significant association between ICG and graft survival after one year [<xref ref-type="bibr" rid="CR32">32</xref>].</p></sec><sec id="Sec17"><title>Future perspective</title><p id="Par84">Currently, obtaining real-time data is not feasible, as processing HSI images is a prerequisite. Real-time HSI could allow an immediate intraoperative evaluation of the kidney parenchyma. In combination with artificial intelligence [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>], further applications of HSI are conceivable, such as organ quality assessment during ex vivo machine perfusion before transplant. The pretransplant evaluation of ECD kidneys would be particularly relevant in this context. Finally, HSI could support the transplant surgeon in challenging graft implantations (for instance, in organs needing difficult vascular reconstruction) or during organ reperfusion to adjust the inflow pressure.</p></sec><sec id="Sec18"><title>Limitations</title><p id="Par85">The major limitations of our study are the small sample size and its single-center character. Therefore, survival analysis has low statistical power, and multivariate Cox regression was not suitable. A further limitation was the measurement of a single time point, which precluded the possibility of conducting a time dependent HSI analysis. Regarding the technique, HSI lacks the capability for continuous postoperative organ monitoring, as a close, direct view of the organ is necessary. Furthermore, the low penetration depth only represents superficial tissue layers, providing no information about the entire organ. Therefore, calibration with the results of another diagnostic tool, such as Doppler ultrasound, should be performed to validate the HSI data.</p></sec></sec><sec id="Sec19"><title>Conclusion</title><p id="Par86">HSI is an efficient, non-invasive tool for quantitative assessment of micro-perfusion and oxygenation, allowing objective evaluation of graft viability after reperfusion. However, further studies are necessary to validate HSI-data and its association with long-term graft survival, especially in LD-KT.</p></sec><sec id="Sec20" sec-type="supplementary-material"><title>Supplementary Information</title><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="12880_2025_1576_MOESM1_ESM.xlsx"><caption><p>Supplementary Material 1:&#x000a0;Supplemental Table&#x000a0;1. Bootstrap analysis of HSI-data for development of delayed graft function.</p></caption></media></supplementary-material></p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>AUC</term><def><p id="Par5">Area under the curve</p></def></def-item><def-item><term>BMI</term><def><p id="Par6">Body mass index</p></def></def-item><def-item><term>CI</term><def><p id="Par7">Confidence interval</p></def></def-item><def-item><term>CIT</term><def><p id="Par8">Cold ischemia time</p></def></def-item><def-item><term>CVA</term><def><p id="Par9">Cerebrovascular accident</p></def></def-item><def-item><term>DD</term><def><p id="Par10">Deceased donor</p></def></def-item><def-item><term>DGF</term><def><p id="Par11">Delayed graft function</p></def></def-item><def-item><term>ECD</term><def><p id="Par12">Expanded criteria donor</p></def></def-item><def-item><term>ESRD</term><def><p id="Par13">End-stage renal disease</p></def></def-item><def-item><term>FOV</term><def><p id="Par14">Field of view</p></def></def-item><def-item><term>GFR</term><def><p id="Par15">Glomerular filtration rate</p></def></def-item><def-item><term>GN</term><def><p id="Par16">Glomerulonephritis</p></def></def-item><def-item><term>HSI</term><def><p id="Par17">Hyperspectral imaging</p></def></def-item><def-item><term>ICU</term><def><p id="Par18">Intensive care unit</p></def></def-item><def-item><term>INF</term><def><p id="Par19">Initial non-function</p></def></def-item><def-item><term>IRI</term><def><p id="Par20">Ischemia reperfusion injury</p></def></def-item><def-item><term>KT</term><def><p id="Par21">Kidney transplantation</p></def></def-item><def-item><term>LD</term><def><p id="Par22">Living donor</p></def></def-item><def-item><term>nDGF</term><def><p id="Par23">Non-delayed graft function</p></def></def-item><def-item><term>NIR</term><def><p id="Par24">Near-infrared perfusion index</p></def></def-item><def-item><term>OHI</term><def><p id="Par25">Organ hemoglobin index</p></def></def-item><def-item><term>RGB</term><def><p id="Par26">Red, green, blue</p></def></def-item><def-item><term>RI</term><def><p id="Par27">Resistive index</p></def></def-item><def-item><term>ROC</term><def><p id="Par28">Receiver operating characteristic</p></def></def-item><def-item><term>ROI</term><def><p id="Par29">Region of interest</p></def></def-item><def-item><term>SCD</term><def><p id="Par30">Standard Criteria donor</p></def></def-item><def-item><term>SD</term><def><p id="Par31">Standard deviation</p></def></def-item><def-item><term>StO<sub>2</sub></term><def><p id="Par32">Tissue oxygenation</p></def></def-item><def-item><term>TWI</term><def><p id="Par33">Tissue water index</p></def></def-item><def-item><term>WIT</term><def><p id="Par34">Warm ischemia time</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Rasmus Wrigge and Robert Sucher contributed equally to this work.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors are grateful to David Petroff, PhD for his contribution to statistical analysis. HMT was supported by the German Research Foundation (DFG) within the Research Unit Program FOR 5151 "QuaLiPerF (Quantifying Liver Perfusion-Function Relationship in Complex Resection - A Systems Medicine Approach)" by grant number 436883643. HMT was supported by the DFG by grant number 465194077 (Priority Programme SPP 2311, Subproject SimLivA). HMT was supported by the Federal Ministry of Education and Research (BMBF, Germany) within ATLAS (grant number 031L0304B).</p></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>RW, US and RS were responsible for the study conception and design; RW and RS were responsible for data acquisition; RW and US analyzed and interpreted the data; US drafted the manuscript; and FH, HJM, JU, HMH, MM, HMT and DS critically revised the manuscript. All authors read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Open Access funding enabled and organized by Projekt DEAL. This work was supported by the Open Access Publication Fund of the University of Leipzig. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no potential conflicts of interest arising from associations with commercial or corporate interests in connection with the work submitted.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>Our database contains highly sensible data which may provide insight in clinical and personnel information about our patients and lead to identification of these patients. Therefore, according to organizational restrictions and regulations these data cannot be made publicly available. However, the datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par87">The study was approved by the local ethical commission board from the University of Leipzig (AZ EK: 111-16-14032016). Written informed consent from any patient for data collection in a prospectively collected data base is available. However, written informed consent to the study was waived by the local Ethics Committee (Ethics Committee of the first affiliated University Hospital of Leipzig University) in view of the retrospective design of the study, accordingly the national and local guidelines such as the fact that all clinical/ laboratory measurements and procedures were part of the routine care.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par88">Not applicable.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par89">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>PS</given-names></name><name><surname>Schaubel</surname><given-names>DE</given-names></name><name><surname>Guidinger</surname><given-names>MK</given-names></name><name><surname>Andreoni</surname><given-names>KA</given-names></name><name><surname>Wolfe</surname><given-names>RA</given-names></name><name><surname>Merion</surname><given-names>RM</given-names></name><name><surname>Port</surname><given-names>FK</given-names></name><name><surname>Sung</surname><given-names>RS</given-names></name></person-group><article-title>A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index</article-title><source>Transplantation</source><year>2009</year><volume>88</volume><issue>2</issue><fpage>231</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1097/TP.0b013e3181ac620b</pub-id><pub-id pub-id-type="pmid">19623019</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Rao PS, Schaubel DE, Guidinger MK, Andreoni KA, Wolfe RA, Merion RM, Port FK, Sung RS. A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index. Transplantation. 2009;88(2):231&#x02013;6. 10.1097/TP.0b013e3181ac620b. PMID: 19623019.<pub-id pub-id-type="pmid">19623019</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Scheuermann</surname><given-names>U</given-names></name><name><surname>Babel</surname><given-names>J</given-names></name><name><surname>Pietsch</surname><given-names>UC</given-names></name><name><surname>Weimann</surname><given-names>A</given-names></name><name><surname>Lyros</surname><given-names>O</given-names></name><name><surname>Semmling</surname><given-names>K</given-names></name><name><surname>Hau</surname><given-names>HM</given-names></name><name><surname>Seehofer</surname><given-names>D</given-names></name><name><surname>Rademacher</surname><given-names>S</given-names></name><name><surname>Sucher</surname><given-names>R</given-names></name></person-group><article-title>Recipient obesity as a risk factor in kidney transplantation</article-title><source>BMC Nephrol</source><year>2022</year><volume>23</volume><issue>1</issue><fpage>37</fpage><pub-id pub-id-type="doi">10.1186/s12882-022-02668-z</pub-id><pub-id pub-id-type="pmid">35042452</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Scheuermann U, Babel J, Pietsch UC, Weimann A, Lyros O, Semmling K, Hau HM, Seehofer D, Rademacher S, Sucher R. Recipient obesity as a risk factor in kidney transplantation. BMC Nephrol. 2022;23(1):37. 10.1186/s12882-022-02668-z. PMID: 35042452; PMCID: PMC8767742.<pub-id pub-id-type="pmid">35042452</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Yarlagadda</surname><given-names>SG</given-names></name><name><surname>Coca</surname><given-names>SG</given-names></name><name><surname>Formica</surname><given-names>RN</given-names><suffix>Jr</suffix></name><name><surname>Poggio</surname><given-names>ED</given-names></name><name><surname>Parikh</surname><given-names>CR</given-names></name></person-group><article-title>Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis</article-title><source>Nephrol Dial Transpl</source><year>2009</year><volume>24</volume><issue>3</issue><fpage>1039</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1093/ndt/gfn667</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Yarlagadda SG, Coca SG, Formica RN Jr, Poggio ED, Parikh CR. Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. Nephrol Dial Transpl. 2009;24(3):1039&#x02013;47. 10.1093/ndt/gfn667. Epub 2008 Dec 22. PMID: 19103734.</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Irish</surname><given-names>WD</given-names></name><name><surname>Ilsley</surname><given-names>JN</given-names></name><name><surname>Schnitzler</surname><given-names>MA</given-names></name><name><surname>Feng</surname><given-names>S</given-names></name><name><surname>Brennan</surname><given-names>DC</given-names></name></person-group><article-title>A risk prediction model for delayed graft function in the current era of deceased donor renal transplantation</article-title><source>Am J Transplant</source><year>2010</year><volume>10</volume><issue>10</issue><fpage>2279</fpage><lpage>2286</lpage><pub-id pub-id-type="doi">10.1111/j.1600-6143.2010.03179.x</pub-id><pub-id pub-id-type="pmid">20883559</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Irish WD, Ilsley JN, Schnitzler MA, Feng S, Brennan DC. A risk prediction model for delayed graft function in the current era of deceased donor renal transplantation. Am J Transplant. 2010;10(10):2279&#x02013;86. 10.1111/j.1600-6143.2010.03179.x. PMID: 20883559.<pub-id pub-id-type="pmid">20883559</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Sucher</surname><given-names>R</given-names></name><name><surname>Athanasios</surname><given-names>A</given-names></name><name><surname>K&#x000f6;hler</surname><given-names>H</given-names></name><name><surname>Wagner</surname><given-names>T</given-names></name><name><surname>Brunotte</surname><given-names>M</given-names></name><name><surname>Lederer</surname><given-names>A</given-names></name><name><surname>Gockel</surname><given-names>I</given-names></name><name><surname>Seehofer</surname><given-names>D</given-names></name></person-group><article-title>Hyperspectral imaging (HSI) in anatomic left liver resection</article-title><source>Int J Surg Case Rep</source><year>2019</year><volume>62</volume><fpage>108</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1016/j.ijscr.2019.08.025</pub-id><pub-id pub-id-type="pmid">31493663</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Sucher R, Athanasios A, K&#x000f6;hler H, Wagner T, Brunotte M, Lederer A, Gockel I, Seehofer D. Hyperspectral imaging (HSI) in anatomic left liver resection. Int J Surg Case Rep. 2019;62:108&#x02013;11. 10.1016/j.ijscr.2019.08.025. Epub 2019 Aug 31. PMID: 31493663; PMCID: PMC6731347.<pub-id pub-id-type="pmid">31493663</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Moulla</surname><given-names>Y</given-names></name><name><surname>Buchloh</surname><given-names>DC</given-names></name><name><surname>K&#x000f6;hler</surname><given-names>H</given-names></name><name><surname>Rademacher</surname><given-names>S</given-names></name><name><surname>Denecke</surname><given-names>T</given-names></name><name><surname>Meyer</surname><given-names>HJ</given-names></name><name><surname>Mehdorn</surname><given-names>M</given-names></name><name><surname>Lange</surname><given-names>UG</given-names></name><name><surname>Sucher</surname><given-names>R</given-names></name><name><surname>Seehofer</surname><given-names>D</given-names></name><name><surname>Jansen-Winkeln</surname><given-names>B</given-names></name><name><surname>Gockel</surname><given-names>I</given-names></name></person-group><article-title>Hyperspectral imaging (HSI)-a new tool to estimate the perfusion of upper abdominal organs during pancreatoduodenectomy</article-title><source>Cancers (Basel)</source><year>2021</year><volume>13</volume><issue>11</issue><fpage>2846</fpage><pub-id pub-id-type="doi">10.3390/cancers13112846</pub-id><pub-id pub-id-type="pmid">34200412</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Moulla Y, Buchloh DC, K&#x000f6;hler H, Rademacher S, Denecke T, Meyer HJ, Mehdorn M, Lange UG, Sucher R, Seehofer D, Jansen-Winkeln B, Gockel I. Hyperspectral imaging (HSI)-a new tool to estimate the perfusion of upper abdominal organs during pancreatoduodenectomy. Cancers (Basel). 2021;13(11): 2846. 10.3390/cancers13112846. PMID: 34200412; PMCID: PMC8201356.<pub-id pub-id-type="pmid">34200412</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Barberio</surname><given-names>M</given-names></name><name><surname>Lapergola</surname><given-names>A</given-names></name><name><surname>Benedicenti</surname><given-names>S</given-names></name><name><surname>Mita</surname><given-names>M</given-names></name><name><surname>Barbieri</surname><given-names>V</given-names></name><name><surname>Rubichi</surname><given-names>F</given-names></name><name><surname>Altamura</surname><given-names>A</given-names></name><name><surname>Giaracuni</surname><given-names>G</given-names></name><name><surname>Tamburini</surname><given-names>E</given-names></name><name><surname>Diana</surname><given-names>M</given-names></name><name><surname>Pizzicannella</surname><given-names>M</given-names></name><name><surname>Viola</surname><given-names>MG</given-names></name></person-group><article-title>Intraoperative bowel perfusion quantification with hyperspectral imaging: a guidance tool for precision colorectal surgery</article-title><source>Surg Endosc</source><year>2022</year><volume>36</volume><issue>11</issue><fpage>8520</fpage><lpage>8532</lpage><pub-id pub-id-type="doi">10.1007/s00464-022-09407-3</pub-id><pub-id pub-id-type="pmid">35836033</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Barberio M, Lapergola A, Benedicenti S, Mita M, Barbieri V, Rubichi F, Altamura A, Giaracuni G, Tamburini E, Diana M, Pizzicannella M, Viola MG. Intraoperative bowel perfusion quantification with hyperspectral imaging: a guidance tool for precision colorectal surgery. Surg Endosc. 2022;36(11):8520&#x02013;32 Epub 2022 Jul 14. PMID: 35836033.<pub-id pub-id-type="pmid">35836033</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Renna</surname><given-names>MS</given-names></name><name><surname>Grzeda</surname><given-names>MT</given-names></name><name><surname>Bailey</surname><given-names>J</given-names></name><name><surname>Hainsworth</surname><given-names>A</given-names></name><name><surname>Ourselin</surname><given-names>S</given-names></name><name><surname>Ebner</surname><given-names>M</given-names></name><name><surname>Vercauteren</surname><given-names>T</given-names></name><name><surname>Schizas</surname><given-names>A</given-names></name><name><surname>Shapey</surname><given-names>J</given-names></name></person-group><article-title>Intraoperative bowel perfusion assessment methods and their effects on anastomotic leak rates: meta-analysis</article-title><source>Br J Surg</source><year>2023</year><volume>110</volume><issue>9</issue><fpage>1131</fpage><lpage>1142</lpage><pub-id pub-id-type="doi">10.1093/bjs/znad154</pub-id><pub-id pub-id-type="pmid">37253021</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Renna MS, Grzeda MT, Bailey J, Hainsworth A, Ourselin S, Ebner M, Vercauteren T, Schizas A, Shapey J. Intraoperative bowel perfusion assessment methods and their effects on anastomotic leak rates: meta-analysis. Br J Surg. 2023;110(9):1131&#x02013;42. 10.1093/bjs/znad154. PMID: 37253021; PMCID: PMC10416696.<pub-id pub-id-type="pmid">37253021</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Kulcke</surname><given-names>A</given-names></name><name><surname>Holmer</surname><given-names>A</given-names></name><name><surname>Wahl</surname><given-names>P</given-names></name><name><surname>Siemers</surname><given-names>F</given-names></name><name><surname>Wild</surname><given-names>T</given-names></name><name><surname>Daeschlein</surname><given-names>G</given-names></name></person-group><article-title>A compact hyperspectral camera for measurement of perfusion parameters in medicine</article-title><source>Biomed Tech (Berl)</source><year>2018</year><volume>63</volume><issue>5</issue><fpage>519</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1515/bmt-2017-0145</pub-id><pub-id pub-id-type="pmid">29522415</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Kulcke A, Holmer A, Wahl P, Siemers F, Wild T, Daeschlein G. A compact hyperspectral camera for measurement of perfusion parameters in medicine. Biomed Tech (Berl). 2018;63(5):519&#x02013;27. 10.1515/bmt-2017-0145. PMID: 29522415.<pub-id pub-id-type="pmid">29522415</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Sucher</surname><given-names>R</given-names></name><name><surname>Wagner</surname><given-names>T</given-names></name><name><surname>K&#x000f6;hler</surname><given-names>H</given-names></name><name><surname>Sucher</surname><given-names>E</given-names></name><name><surname>Quice</surname><given-names>H</given-names></name><name><surname>Recknagel</surname><given-names>S</given-names></name><name><surname>Lederer</surname><given-names>A</given-names></name><name><surname>Hau</surname><given-names>HM</given-names></name><name><surname>Rademacher</surname><given-names>S</given-names></name><name><surname>Schneeberger</surname><given-names>S</given-names></name><name><surname>Brandacher</surname><given-names>G</given-names></name><name><surname>Gockel</surname><given-names>I</given-names></name><name><surname>Seehofer</surname><given-names>D</given-names></name></person-group><article-title>Hyperspectral imaging (HSI) of human kidney allografts</article-title><source>Ann Surg</source><year>2022</year><volume>276</volume><issue>1</issue><fpage>e48</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1097/SLA.0000000000004429</pub-id><pub-id pub-id-type="pmid">33196483</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Sucher R, Wagner T, K&#x000f6;hler H, Sucher E, Quice H, Recknagel S, Lederer A, Hau HM, Rademacher S, Schneeberger S, Brandacher G, Gockel I, Seehofer D. Hyperspectral imaging (HSI) of human kidney allografts. Ann Surg. 2022;276(1):e48-55. 10.1097/SLA.0000000000004429. Epub 2020 Nov 13. PMID: 33196483.<pub-id pub-id-type="pmid">33196483</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Romann</surname><given-names>S</given-names></name><name><surname>Wagner</surname><given-names>T</given-names></name><name><surname>Katou</surname><given-names>S</given-names></name><name><surname>Reuter</surname><given-names>S</given-names></name><name><surname>Vogel</surname><given-names>T</given-names></name><name><surname>Becker</surname><given-names>F</given-names></name><name><surname>Morgul</surname><given-names>H</given-names></name><name><surname>Houben</surname><given-names>P</given-names></name><name><surname>Wahl</surname><given-names>P</given-names></name><name><surname>Pascher</surname><given-names>A</given-names></name><name><surname>Radunz</surname><given-names>S</given-names></name></person-group><article-title>Hyperspectral imaging for assessment of initial graft function in human kidney transplantation</article-title><source>Diagnostics (Basel)</source><year>2022</year><volume>12</volume><issue>5</issue><fpage>1194</fpage><pub-id pub-id-type="doi">10.3390/diagnostics12051194</pub-id><pub-id pub-id-type="pmid">35626349</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Romann S, Wagner T, Katou S, Reuter S, Vogel T, Becker F, Morgul H, Houben P, Wahl P, Pascher A, Radunz S. Hyperspectral imaging for assessment of initial graft function in human kidney transplantation. Diagnostics (Basel). 2022;12(5): 1194. 10.3390/diagnostics12051194. PMID: 35626349; PMCID: PMC9139834.<pub-id pub-id-type="pmid">35626349</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Levey</surname><given-names>AS</given-names></name><name><surname>Stevens</surname><given-names>LA</given-names></name><name><surname>Schmid</surname><given-names>CH</given-names></name><name><surname>Zhang</surname><given-names>YL</given-names></name><name><surname>Castro</surname><given-names>AF</given-names><suffix>3rd</suffix></name><name><surname>Feldman</surname><given-names>HI</given-names></name><name><surname>Kusek</surname><given-names>JW</given-names></name><name><surname>Eggers</surname><given-names>P</given-names></name><name><surname>Van Lente</surname><given-names>F</given-names></name><name><surname>Greene</surname><given-names>T</given-names></name><name><surname>Coresh</surname><given-names>J</given-names></name></person-group><article-title>A new equation to estimate glomerular filtration rate</article-title><source>Ann Intern Med</source><year>2009</year><volume>150</volume><issue>9</issue><fpage>604</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-150-9-200905050-00006</pub-id><pub-id pub-id-type="pmid">19414839</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604&#x02013;12. 10.7326/0003-4819-150-9-200905050-00006. Erratum in: Ann Intern Med. 2011 Sep 20;155(6):408. PMID: 19414839; PMCID: PMC2763564.<pub-id pub-id-type="pmid">19414839</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>PS</given-names></name><name><surname>Ojo</surname><given-names>A</given-names></name></person-group><article-title>The alphabet soup of kidney transplantation: SCD, DCD, ECD&#x02013;fundamentals for the practicing nephrologist</article-title><source>Clin J Am Soc Nephrol</source><year>2009</year><volume>4</volume><issue>11</issue><fpage>1827</fpage><lpage>1831</lpage><pub-id pub-id-type="doi">10.2215/CJN.02270409</pub-id><pub-id pub-id-type="pmid">19808229</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Rao PS, Ojo A. The alphabet soup of kidney transplantation: SCD, DCD, ECD&#x02013;fundamentals for the practicing nephrologist. Clin J Am Soc Nephrol. 2009;4(11):1827&#x02013;31. 10.2215/CJN.02270409. Epub 2009 Sep 24. PMID: 19808229.<pub-id pub-id-type="pmid">19808229</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Siedlecki</surname><given-names>A</given-names></name><name><surname>Irish</surname><given-names>W</given-names></name><name><surname>Brennan</surname><given-names>DC</given-names></name></person-group><article-title>Delayed graft function in the kidney transplant</article-title><source>Am J Transplant</source><year>2011</year><volume>11</volume><issue>11</issue><fpage>2279</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1111/j.1600-6143.2011.03754.x</pub-id><pub-id pub-id-type="pmid">21929642</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Siedlecki A, Irish W, Brennan DC. Delayed graft function in the kidney transplant. Am J Transplant. 2011;11(11):2279&#x02013;96. 10.1111/j.1600-6143.2011.03754.x. Epub 2011 Sep 19. PMID: 21929642; PMCID: PMC3280444.<pub-id pub-id-type="pmid">21929642</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Holmer</surname><given-names>A</given-names></name><name><surname>Tetschke</surname><given-names>F</given-names></name><name><surname>Marotz</surname><given-names>J</given-names></name><name><surname>Malberg</surname><given-names>H</given-names></name><name><surname>Markgraf</surname><given-names>W</given-names></name><name><surname>Thiele</surname><given-names>C</given-names></name><name><surname>Kulcke</surname><given-names>A</given-names></name></person-group><article-title>Oxygenation and perfusion monitoring with a hyperspectral camera system for chemical based tissue analysis of skin and organs</article-title><source>Physiol Meas</source><year>2016</year><volume>37</volume><issue>11</issue><fpage>2064</fpage><lpage>2078</lpage><pub-id pub-id-type="doi">10.1088/0967-3334/37/11/2064</pub-id><pub-id pub-id-type="pmid">27786164</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Holmer A, Tetschke F, Marotz J, Malberg H, Markgraf W, Thiele C, Kulcke A. Oxygenation and perfusion monitoring with a hyperspectral camera system for chemical based tissue analysis of skin and organs. Physiol Meas. 2016;37(11):2064&#x02013;78. 10.1088/0967-3334/37/11/2064. Epub 2016 Oct 27. PMID: 27786164.<pub-id pub-id-type="pmid">27786164</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Sucher</surname><given-names>R</given-names></name><name><surname>Scheuermann</surname><given-names>U</given-names></name><name><surname>Rademacher</surname><given-names>S</given-names></name><name><surname>Lederer</surname><given-names>A</given-names></name><name><surname>Sucher</surname><given-names>E</given-names></name><name><surname>Hau</surname><given-names>HM</given-names></name><name><surname>Brandacher</surname><given-names>G</given-names></name><name><surname>Schneeberger</surname><given-names>S</given-names></name><name><surname>Gockel</surname><given-names>I</given-names></name><name><surname>Seehofer</surname><given-names>D</given-names></name></person-group><article-title>Intraoperative reperfusion assessment of human pancreas allografts using hyperspectral imaging (HSI)</article-title><source>Hepatobiliary Surg Nutr</source><year>2022</year><volume>11</volume><issue>1</issue><fpage>67</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.21037/hbsn-20-744</pub-id><pub-id pub-id-type="pmid">35284501</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Sucher R, Scheuermann U, Rademacher S, Lederer A, Sucher E, Hau HM, Brandacher G, Schneeberger S, Gockel I, Seehofer D. Intraoperative reperfusion assessment of human pancreas allografts using hyperspectral imaging (HSI). Hepatobiliary Surg Nutr. 2022;11(1):67&#x02013;77. 10.21037/hbsn-20-744.<pub-id pub-id-type="pmid">35284501</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Holmer</surname><given-names>A</given-names></name><name><surname>Marotz</surname><given-names>J</given-names></name><name><surname>Wahl</surname><given-names>P</given-names></name><name><surname>Dau</surname><given-names>M</given-names></name><name><surname>K&#x000e4;mmerer</surname><given-names>PW</given-names></name></person-group><article-title>Hyperspectral imaging in perfusion and wound diagnostics - methods and algorithms for the determination of tissue parameters</article-title><source>Biomed Tech (Berl)</source><year>2018</year><volume>63</volume><issue>5</issue><fpage>547</fpage><lpage>556</lpage><pub-id pub-id-type="doi">10.1515/bmt-2017-0155</pub-id><pub-id pub-id-type="pmid">30028724</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Holmer A, Marotz J, Wahl P, Dau M, K&#x000e4;mmerer PW. Hyperspectral imaging in perfusion and wound diagnostics - methods and algorithms for the determination of tissue parameters. Biomed Tech (Berl). 2018;63(5):547&#x02013;56. 10.1515/bmt-2017-0155. PMID: 30028724.<pub-id pub-id-type="pmid">30028724</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Youden</surname><given-names>WJ</given-names></name></person-group><article-title>Index for rating diagnostic tests</article-title><source>Cancer</source><year>1950</year><volume>3</volume><issue>1</issue><fpage>32</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1002/1097-0142(1950)3:1&#x0003c;32::AID-CNCR2820030106&#x0003e;3.0.CO;2-3</pub-id><pub-id pub-id-type="pmid">15405679</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3(1):32&#x02013;5. https://doi.org/10.1002/1097-0142(1950)3:1&#x0003c;32::aid-cncr2820030106&#x0003e;3.0.co;2-3. PMID: 15405679.<pub-id pub-id-type="pmid">15405679</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Schaapherder</surname><given-names>AF</given-names></name><name><surname>Kaisar</surname><given-names>M</given-names></name><name><surname>Mumford</surname><given-names>L</given-names></name><name><surname>Robb</surname><given-names>M</given-names></name><name><surname>Johnson</surname><given-names>R</given-names></name><name><surname>de Kok</surname><given-names>MJC</given-names></name><name><surname>Bemelman</surname><given-names>FJ</given-names></name><name><surname>van de Wetering</surname><given-names>J</given-names></name><name><surname>van Zuilen</surname><given-names>AD</given-names></name><name><surname>Christiaans</surname><given-names>MHL</given-names></name><name><surname>Baas</surname><given-names>MC</given-names></name><name><surname>Nurmohamed</surname><given-names>AS</given-names></name><name><surname>Berger</surname><given-names>SP</given-names></name><name><surname>Bastiaannet</surname><given-names>E</given-names></name><name><surname>de Vries</surname><given-names>APJ</given-names></name><name><surname>Sharples</surname><given-names>E</given-names></name><name><surname>Ploeg</surname><given-names>RJ</given-names></name><name><surname>Lindeman</surname><given-names>JHN</given-names></name></person-group><article-title>Donor characteristics and their impact on kidney transplantation outcomes: results from two nationwide instrumental variable analyses based on outcomes of donor kidney pairs accepted for transplantation</article-title><source>EClinicalMedicine</source><year>2022</year><volume>50</volume><fpage>101516</fpage><pub-id pub-id-type="doi">10.1016/j.eclinm.2022.101516</pub-id><pub-id pub-id-type="pmid">35784435</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Schaapherder AF, Kaisar M, Mumford L, Robb M, Johnson R, de Kok MJC, Bemelman FJ, van de Wetering J, van Zuilen AD, Christiaans MHL, Baas MC, Nurmohamed AS, Berger SP, Bastiaannet E, de Vries APJ, Sharples E, Ploeg RJ, Lindeman JHN. Donor characteristics and their impact on kidney transplantation outcomes: results from two nationwide instrumental variable analyses based on outcomes of donor kidney pairs accepted for transplantation. EClinicalMedicine. 2022;50:101516. 10.1016/j.eclinm.2022.101516. PMID: 35784435; PMCID: PMC9240982.<pub-id pub-id-type="pmid">35784435</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Castro Filho</surname><given-names>JBS</given-names></name><name><surname>Pompeo</surname><given-names>JC</given-names></name><name><surname>Machado</surname><given-names>RB</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>LFS</given-names></name><name><surname>Bauer</surname><given-names>AC</given-names></name><name><surname>Manfro</surname><given-names>RC</given-names></name></person-group><article-title>Delayed graft function under the microscope: surveillance biopsies in kidney transplantation</article-title><source>Transpl Int</source><year>2022</year><volume>35</volume><fpage>10344</fpage><pub-id pub-id-type="doi">10.3389/ti.2022.10344</pub-id><pub-id pub-id-type="pmid">35401043</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Castro Filho JBS, Pompeo JC, Machado RB, Gon&#x000e7;alves LFS, Bauer AC, Manfro RC. Delayed graft function under the microscope: surveillance biopsies in kidney transplantation. Transpl Int. 2022;35:10344. 10.3389/ti.2022.10344. PMID: 35401043; PMCID: PMC8988887.<pub-id pub-id-type="pmid">35401043</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Moein</surname><given-names>M</given-names></name><name><surname>Papa</surname><given-names>S</given-names></name><name><surname>Ortiz</surname><given-names>N</given-names></name><name><surname>Saidi</surname><given-names>R</given-names></name></person-group><article-title>Protocol biopsy after kidney transplant: clinical application and efficacy to detect allograft rejection</article-title><source>Cureus</source><year>2023</year><volume>15</volume><issue>2</issue><fpage>e34505</fpage><pub-id pub-id-type="doi">10.7759/cureus.34505</pub-id><pub-id pub-id-type="pmid">36874304</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Moein M, Papa S, Ortiz N, Saidi R. Protocol biopsy after kidney transplant: clinical application and efficacy to detect allograft rejection. Cureus. 2023;15(2):e34505. 10.7759/cureus.34505. PMID: 36874304; PMCID: PMC9983784.<pub-id pub-id-type="pmid">36874304</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Montagud-Marrahi</surname><given-names>E</given-names></name><name><surname>Molina-And&#x000fa;jar</surname><given-names>A</given-names></name><name><surname>Rovira</surname><given-names>J</given-names></name><name><surname>Revuelta</surname><given-names>I</given-names></name><name><surname>Ventura-Aguiar</surname><given-names>P</given-names></name><name><surname>Pi&#x000f1;eiro</surname><given-names>G</given-names></name><name><surname>Ugalde-Altamirano</surname><given-names>J</given-names></name><name><surname>Perna</surname><given-names>F</given-names></name><name><surname>Torregrosa</surname><given-names>JV</given-names></name><name><surname>Oppenheimer</surname><given-names>F</given-names></name><name><surname>Esforzado</surname><given-names>N</given-names></name><name><surname>Cof&#x000e1;n</surname><given-names>F</given-names></name><name><surname>Campistol</surname><given-names>JM</given-names></name><name><surname>Herrera-Garcia</surname><given-names>A</given-names></name><name><surname>R&#x000ed;os</surname><given-names>J</given-names></name><name><surname>Diekmann</surname><given-names>F</given-names></name><name><surname>Cucchiari</surname><given-names>D</given-names></name></person-group><article-title>The impact of functional delayed graft function in the modern era of kidney transplantation - a retrospective study</article-title><source>Transpl Int</source><year>2021</year><volume>34</volume><issue>1</issue><fpage>175</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1111/tri.13781</pub-id><pub-id pub-id-type="pmid">33131120</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Montagud-Marrahi E, Molina-And&#x000fa;jar A, Rovira J, Revuelta I, Ventura-Aguiar P, Pi&#x000f1;eiro G, Ugalde-Altamirano J, Perna F, Torregrosa JV, Oppenheimer F, Esforzado N, Cof&#x000e1;n F, Campistol JM, Herrera-Garcia A, R&#x000ed;os J, Diekmann F, Cucchiari D. The impact of functional delayed graft function in the modern era of kidney transplantation - a retrospective study. Transpl Int. 2021;34(1):175&#x02013;84. 10.1111/tri.13781. Epub 2020 Nov 28. PMID: 33131120.<pub-id pub-id-type="pmid">33131120</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>DW</given-names></name><name><surname>Tsapepas</surname><given-names>D</given-names></name><name><surname>King</surname><given-names>KL</given-names></name><name><surname>Husain</surname><given-names>SA</given-names></name><name><surname>Corvino</surname><given-names>FA</given-names></name><name><surname>Dillon</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Mayne</surname><given-names>TJ</given-names></name><name><surname>Mohan</surname><given-names>S</given-names></name></person-group><article-title>Financial impact of delayed graft function in kidney transplantation</article-title><source>Clin Transplant</source><year>2020</year><volume>34</volume><issue>10</issue><fpage>e14022</fpage><pub-id pub-id-type="doi">10.1111/ctr.14022</pub-id><pub-id pub-id-type="pmid">32573812</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Kim DW, Tsapepas D, King KL, Husain SA, Corvino FA, Dillon A, Wang W, Mayne TJ, Mohan S. Financial impact of delayed graft function in kidney transplantation. Clin Transplant. 2020;34(10):e14022. 10.1111/ctr.14022. Epub 2020 Aug 11. PMID: 32573812; PMCID: PMC8415124.<pub-id pub-id-type="pmid">32573812</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Ponticelli</surname><given-names>C</given-names></name></person-group><article-title>Ischaemia-reperfusion injury: a major protagonist in kidney transplantation</article-title><source>Nephrol Dial Transplant</source><year>2014</year><volume>29</volume><issue>6</issue><fpage>1134</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1093/ndt/gft488</pub-id><pub-id pub-id-type="pmid">24335382</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Ponticelli C. Ischaemia-reperfusion injury: a major protagonist in kidney transplantation. Nephrol Dial Transplant. 2014;29(6):1134&#x02013;40. 10.1093/ndt/gft488. Epub 2013 Dec 10. PMID: 24335382.<pub-id pub-id-type="pmid">24335382</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Salvadori</surname><given-names>M</given-names></name><name><surname>Tsalouchos</surname><given-names>A</given-names></name></person-group><article-title>Biomarkers in renal transplantation: an updated review</article-title><source>World J Transplant</source><year>2017</year><volume>7</volume><issue>3</issue><fpage>161</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.5500/wjt.v7.i3.161</pub-id><pub-id pub-id-type="pmid">28698834</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Salvadori M, Tsalouchos A. Biomarkers in renal transplantation: an updated review. World J Transplant. 2017;7(3):161&#x02013;78. 10.5500/wjt.v7.i3.161. PMID: 28698834; PMCID: PMC5487307.<pub-id pub-id-type="pmid">28698834</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>van Duijl</surname><given-names>TT</given-names></name><name><surname>de Rooij</surname><given-names>ENM</given-names></name><name><surname>Treep</surname><given-names>MM</given-names></name><name><surname>Koelemaij</surname><given-names>ME</given-names></name><name><surname>Romijn</surname><given-names>FPHTM</given-names></name><name><surname>Hoogeveen</surname><given-names>EK</given-names></name><name><surname>Ruhaak</surname><given-names>LR</given-names></name><name><surname>le Cessie</surname><given-names>S</given-names></name><name><surname>de Fijter</surname><given-names>JW</given-names></name><name><surname>Cobbaert</surname><given-names>CM</given-names></name></person-group><article-title>Urinary kidney injury biomarkers are associated with ischemia-reperfusion injury severity in kidney allograft recipients</article-title><source>Clin Chem</source><year>2023</year><volume>69</volume><issue>8</issue><fpage>924</fpage><lpage>935</lpage><pub-id pub-id-type="doi">10.1093/clinchem/hvad086</pub-id><pub-id pub-id-type="pmid">37477911</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">van Duijl TT, de Rooij ENM, Treep MM, Koelemaij ME, Romijn FPHTM, Hoogeveen EK, Ruhaak LR, le Cessie S, de Fijter JW, Cobbaert CM. Urinary kidney injury biomarkers are associated with ischemia-reperfusion injury severity in kidney allograft recipients. Clin Chem. 2023;69(8):924&#x02013;35. 10.1093/clinchem/hvad086. PMID: 37477911.<pub-id pub-id-type="pmid">37477911</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Chudek</surname><given-names>J</given-names></name><name><surname>Kolonko</surname><given-names>A</given-names></name><name><surname>Kr&#x000f3;l</surname><given-names>R</given-names></name><name><surname>Ziaja</surname><given-names>J</given-names></name><name><surname>Cierpka</surname><given-names>L</given-names></name><name><surname>Wiecek</surname><given-names>A</given-names></name></person-group><article-title>The intrarenal vascular resistance parameters measured by duplex Doppler ultrasound shortly after kidney transplantation in patients with immediate, slow, and delayed graft function</article-title><source>Transplant Proc</source><year>2006</year><volume>38</volume><issue>1</issue><fpage>42</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1016/j.transproceed.2005.12.013</pub-id><pub-id pub-id-type="pmid">16504659</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Chudek J, Kolonko A, Kr&#x000f3;l R, Ziaja J, Cierpka L, Wiecek A. The intrarenal vascular resistance parameters measured by duplex Doppler ultrasound shortly after kidney transplantation in patients with immediate, slow, and delayed graft function. Transplant Proc. 2006;38(1):42&#x02013;5. 10.1016/j.transproceed.2005.12.013. PMID: 16504659.<pub-id pub-id-type="pmid">16504659</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname><given-names>YJ</given-names></name><name><surname>Chu</surname><given-names>SH</given-names></name><name><surname>Chuang</surname><given-names>CK</given-names></name><name><surname>Chen</surname><given-names>HW</given-names></name><name><surname>Chou</surname><given-names>CC</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>CT</given-names></name></person-group><article-title>Resistive index cannot predict transplant kidney function</article-title><source>Transplant Proc</source><year>2003</year><volume>35</volume><issue>1</issue><fpage>94</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1016/s0041-1345(02)03802-2</pub-id><pub-id pub-id-type="pmid">12591322</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Chiang YJ, Chu SH, Chuang CK, Chen HW, Chou CC, Chen Y, Wu CT. Resistive index cannot predict transplant kidney function. Transplant Proc. 2003;35(1):94&#x02013;5. 10.1016/s0041-1345(02)03802-2. PMID: 12591322.<pub-id pub-id-type="pmid">12591322</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x000f3;mez</surname><given-names>V</given-names></name><name><surname>Orosa</surname><given-names>A</given-names></name><name><surname>Rivera</surname><given-names>M</given-names></name><name><surname>Diez-Nicol&#x000e1;s</surname><given-names>V</given-names></name><name><surname>Hevia</surname><given-names>V</given-names></name><name><surname>Alvarez</surname><given-names>S</given-names></name><name><surname>Carracedo</surname><given-names>D</given-names></name><name><surname>Ramos</surname><given-names>E</given-names></name><name><surname>Burgos</surname><given-names>FJ</given-names></name></person-group><article-title>Resistance index determination in the pre and post kidney transplantation time points in graft dysfunction diagnosis</article-title><source>Transplant Proc</source><year>2015</year><volume>47</volume><issue>1</issue><fpage>34</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.transproceed.2014.11.027</pub-id><pub-id pub-id-type="pmid">25645764</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">G&#x000f3;mez V, Orosa A, Rivera M, Diez-Nicol&#x000e1;s V, Hevia V, Alvarez S, Carracedo D, Ramos E, Burgos FJ. Resistance index determination in the pre and post kidney transplantation time points in graft dysfunction diagnosis. Transplant Proc. 2015;47(1):34&#x02013;7. 10.1016/j.transproceed.2014.11.027. PMID: 25645764.<pub-id pub-id-type="pmid">25645764</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Kr&#x000f3;l</surname><given-names>R</given-names></name><name><surname>Chudek</surname><given-names>J</given-names></name><name><surname>Kolonko</surname><given-names>A</given-names></name><name><surname>Ziaja</surname><given-names>J</given-names></name><name><surname>Pawlicki</surname><given-names>J</given-names></name><name><surname>Wiecek</surname><given-names>A</given-names></name><name><surname>Cierpka</surname><given-names>L</given-names></name></person-group><article-title>Intraoperative resistance index measured with transsonic flowmeter on kidney graft artery can predict early and long-term graft function</article-title><source>Transplant Proc</source><year>2011</year><volume>43</volume><issue>8</issue><fpage>2926</fpage><lpage>2929</lpage><pub-id pub-id-type="doi">10.1016/j.transproceed.2011.08.019</pub-id><pub-id pub-id-type="pmid">21996191</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Kr&#x000f3;l R, Chudek J, Kolonko A, Ziaja J, Pawlicki J, Wiecek A, Cierpka L. Intraoperative resistance index measured with transsonic flowmeter on kidney graft artery can predict early and long-term graft function. Transplant Proc. 2011;43(8):2926&#x02013;9. 10.1016/j.transproceed.2011.08.019. PMID: 21996191.<pub-id pub-id-type="pmid">21996191</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Ietto</surname><given-names>G</given-names></name><name><surname>Zani</surname><given-names>E</given-names></name><name><surname>Benedetti</surname><given-names>F</given-names></name><name><surname>Parise</surname><given-names>C</given-names></name><name><surname>Iori</surname><given-names>V</given-names></name><name><surname>Masci</surname><given-names>F</given-names></name><name><surname>Franchi</surname><given-names>C</given-names></name><name><surname>Ferri</surname><given-names>E</given-names></name><name><surname>Liepa</surname><given-names>L</given-names></name><name><surname>Brusa</surname><given-names>D</given-names></name><name><surname>Oltolina</surname><given-names>M</given-names></name><name><surname>Baglieri</surname><given-names>C</given-names></name><name><surname>Ripamonti</surname><given-names>M</given-names></name><name><surname>Guzzetti</surname><given-names>L</given-names></name><name><surname>Dalla Gasperina</surname><given-names>D</given-names></name><name><surname>Ambrosini</surname><given-names>A</given-names></name><name><surname>Amico</surname><given-names>F</given-names></name><name><surname>Di Saverio</surname><given-names>S</given-names></name><name><surname>Latham</surname><given-names>L</given-names></name><name><surname>Iovino</surname><given-names>D</given-names></name><name><surname>Soldini</surname><given-names>G</given-names></name><name><surname>Tozzi</surname><given-names>M</given-names></name><name><surname>Carcano</surname><given-names>G</given-names></name></person-group><article-title>Indocyanine green angiography for quality assessment of the kidney during transplantation: an outcome predictor prospective study</article-title><source>Transplant Proc</source><year>2021</year><volume>53</volume><issue>6</issue><fpage>1892</fpage><lpage>1896</lpage><pub-id pub-id-type="doi">10.1016/j.transproceed.2021.06.010</pub-id><pub-id pub-id-type="pmid">34233847</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Ietto G, Zani E, Benedetti F, Parise C, Iori V, Masci F, Franchi C, Ferri E, Liepa L, Brusa D, Oltolina M, Baglieri C, Ripamonti M, Guzzetti L, Dalla Gasperina D, Ambrosini A, Amico F, Di Saverio S, Latham L, Iovino D, Soldini G, Tozzi M, Carcano G. Indocyanine green angiography for quality assessment of the kidney during transplantation: an outcome predictor prospective study. Transplant Proc. 2021;53(6):1892&#x02013;6. 10.1016/j.transproceed.2021.06.010. Epub 2021 Jul 5. PMID: 34233847.<pub-id pub-id-type="pmid">34233847</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Gerken</surname><given-names>ALH</given-names></name><name><surname>Nowak</surname><given-names>K</given-names></name><name><surname>Meyer</surname><given-names>A</given-names></name><name><surname>Weiss</surname><given-names>C</given-names></name><name><surname>Kr&#x000fc;ger</surname><given-names>B</given-names></name><name><surname>Nawroth</surname><given-names>N</given-names></name><name><surname>Karampinis</surname><given-names>I</given-names></name><name><surname>Heller</surname><given-names>K</given-names></name><name><surname>Apel</surname><given-names>H</given-names></name><name><surname>Reissfelder</surname><given-names>C</given-names></name><name><surname>Schwenke</surname><given-names>K</given-names></name><name><surname>Keese</surname><given-names>M</given-names></name><name><surname>Lang</surname><given-names>W</given-names></name><name><surname>Rother</surname><given-names>U</given-names></name></person-group><article-title>Quantitative assessment of intraoperative laser fluorescence angiography with indocyanine green predicts early graft function after kidney transplantation</article-title><source>Ann Surg</source><year>2022</year><volume>276</volume><issue>2</issue><fpage>391</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.1097/SLA.0000000000004529</pub-id><pub-id pub-id-type="pmid">33394595</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Gerken ALH, Nowak K, Meyer A, Weiss C, Kr&#x000fc;ger B, Nawroth N, Karampinis I, Heller K, Apel H, Reissfelder C, Schwenke K, Keese M, Lang W, Rother U. Quantitative assessment of intraoperative laser fluorescence angiography with indocyanine green predicts early graft function after kidney transplantation. Ann Surg. 2022;276(2):391&#x02013;7 Epub 2020 Dec 30. PMID: 33394595; PMCID: PMC9259036.<pub-id pub-id-type="pmid">33394595</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Moglia</surname><given-names>A</given-names></name><name><surname>Georgiou</surname><given-names>K</given-names></name><name><surname>Georgiou</surname><given-names>E</given-names></name><name><surname>Satava</surname><given-names>RM</given-names></name><name><surname>Cuschieri</surname><given-names>A</given-names></name></person-group><article-title>A systematic review on artificial intelligence in robot-assisted surgery</article-title><source>Int J Surg</source><year>2021</year><volume>95</volume><fpage>106151</fpage><pub-id pub-id-type="doi">10.1016/j.ijsu.2021.106151</pub-id><pub-id pub-id-type="pmid">34695601</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Moglia A, Georgiou K, Georgiou E, Satava RM, Cuschieri A. A systematic review on artificial intelligence in robot-assisted surgery. Int J Surg. 2021;95:106151. 10.1016/j.ijsu.2021.106151. Epub 2021 Oct 22. PMID: 34695601.<pub-id pub-id-type="pmid">34695601</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Kinoshita</surname><given-names>T</given-names></name><name><surname>Komatsu</surname><given-names>M</given-names></name></person-group><article-title>Artificial intelligence in surgery and its potential for gastric cancer</article-title><source>J Gastric Cancer</source><year>2023</year><volume>23</volume><issue>3</issue><fpage>400</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.5230/jgc.2023.23.e27</pub-id><pub-id pub-id-type="pmid">37553128</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Kinoshita T, Komatsu M. Artificial intelligence in surgery and its potential for gastric cancer. J Gastric Cancer. 2023;23(3):400&#x02013;9. 10.5230/jgc.2023.23.e27. PMID: 37553128; PMCID: PMC10412972.<pub-id pub-id-type="pmid">37553128</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>